Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Mitsubishi Tanabe – Discontinuation of Radicava® (edaravone) intravenous
October 10, 2024 - Mitsubishi Tanabe announced a business decision to discontinue intravenous (IV) Radicava (edaravone). Radicava IV is not being discontinued for reasons of safety or effectiveness.
